FROM ASCO 2024 Asciminib, a first-in-class tyrosine kinase inhibitor (TKI), shows efficacy and significantly improved tolerability compared with standard of care TKIs as a frontline treatment […]

In a study of adults, an increase of 1 g in estimated 24-hour urinary sodium excretion was associated with an 11% higher odds of an atopic […]

Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead with […]

Despite overall declines in cancer incidence and mortality, population growth and aging are predicted to drive an increase in the absolute number of people receiving a […]

A US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for the […]

NASHVILLE, Tennessee — Interventions that stimulate the reward system may be the most effective treatment for fatigue directly related to multiple sclerosis (MS), experts said. Here […]

Exercise interventions are recommended to help prevent falls and fall-related morbidity in community-dwelling adults aged 65 years and older who are at increased risk of falls, […]